Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of DssiTgdPa-HBV-IPV/Hib Vaccine in Infants
NCT00376779Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Primary completion
- May 2007
- Modality
- Split/Subunit Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of diphtheria-tetanus-acellular pertussis (5-component) vaccine + hepatitis B vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by GSK. Started Oct 2006; status: completed.
02
Drugs
diphtheria-tetanus-acellular pertussis (5-component) vaccine + hepatitis B vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00376779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376779.